Skip to main content
HSCS
NASDAQ Crypto Assets

Fortitude Names Jaime Leverton CEO Ahead of HeartSciences Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.865
Mkt Cap
$18.193M
52W Low
$1.63
52W High
$4.35
52W Position info
137% above low
Off High info
11% below high
Rel. Volume
Market data snapshot near publication time

HSCS has more than doubled off its 52-week low of $1.63.

Summary

Fortitude Mining Holdings appointed Jaime Leverton, former Hut 8 CEO, as its new CEO effective September 21, 2026, with Andrea Childs moving to COO. Leverton is expected to lead the combined company after the pending HeartSciences merger closes.


Key Events · Executive and Board Changes · HSCS

  • Fortitude Appoints Jaime Leverton as CEO

    Jaime Leverton, former CEO of Hut 8, becomes CEO of Fortitude Mining Holdings effective September 21, 2026, succeeding Andrea Childs.

  • Andrea Childs Transitions to COO

    Andrea Childs steps down as Fortitude CEO and resigns from the board immediately, becoming Chief Operating Officer effective September 21, 2026.

  • Leverton to Lead Combined Company

    Leverton is expected to serve as CEO and board member of the combined company, to be renamed Fortitude Mining Group, Inc., following the merger closing.

  • Merger Timeline

    The proposed business combination with HeartSciences, announced June 23, 2026, is expected to close in Q4 2026, subject to shareholder approval.


Analysis · HSCS · Crypto Assets

Fortitude Mining Holdings, the target in HeartSciences' pending all-stock merger, has appointed Jaime Leverton as CEO effective September 21, 2026. Leverton, former CEO of Hut 8, brings public-company digital asset mining experience as Fortitude prepares to become the combined company's operating business. Andrea Childs transitions from CEO to COO and resigns from the Fortitude board. The leadership change signals Fortitude is positioning itself for life as a public company, with Leverton expected to lead the combined entity post-merger. This matters because HeartSciences is nearly insolvent — cash of $29,906 and negative equity of $2.03 million as of the last 10-Q — and the merger is its only path to survival. A credible, experienced CEO at the helm of the target company strengthens the case for shareholder approval of the deal.

How filings like this one have moved

In the 30 days to Sep 17, 2026, 29.6% of the 1721 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HSCS was trading at $3.87 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $18.2M. The 52-week trading range was $1.63 to $4.35. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HSCS - Latest Insights

HSCS
Sep 17, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.87
Real-time Price: $3.89 info
Change: +$0.0299 (+0.77%) info
Market Cap: $18.193M info
HSCS
Sep 15, 2026, 5:03 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $3.44
Real-time Price: $3.89 info
Change: +$0.4549 (+13%) info
Market Cap: $18.193M info
HSCS
Sep 15, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.44
Real-time Price: $3.89 info
Change: +$0.4549 (+13%) info
Market Cap: $18.193M info
HSCS
Sep 15, 2026, 9:25 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.54
Real-time Price: $3.89 info
Change: +$0.3549 (+10%) info
Market Cap: $18.193M info
HSCS
Sep 14, 2026, 4:14 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.54
Real-time Price: $3.89 info
Change: +$0.3549 (+10%) info
Market Cap: $18.193M info